MDGL
Madrigal Pharmaceuticals Inc
513.20$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +169.2% | +69.0% | +1.6% | -2.4% | -2.9% | -4.4% | +1.9% | +34.2% | -7.6% | -2.6% | +1.4% | |
| – | +170.6% | +68.5% | +1.7% | -2.6% | -2.9% | -4.4% | +1.6% | +34.2% | -7.5% | -5.1% | +1.4% | |
| – | +61.0% | +523.0% | -20.5% | -53.0% | -57.0% | +83.6% | +1.4% | +58.8% | -32.8% | +16.9% | +26.1% | |
| – | +172.9% | +67.0% | -0.1% | -5.6% | -7.2% | -9.0% | -5.5% | +39.2% | -11.4% | -16.8% | +2.5% | |
| – | – | – | – | +341.6% | +76.7% | +14.1% | +29.0% | +43.0% | +18.7% | +39.3% | +2.6% | |
| – | – | – | +728.1% | +23.2% | +290.9% | +62.1% | +14.9% | +9.2% | +8.0% | +49.7% | -11.3% | |
| – | – | – | -1.8% | -1.9% | -1.9% | -1.9% | -2.0% | +64.4% | -1.3% | -1.3% | -1.3% | |
| – | +9.0% | -1.6% | +4.8% | +22.0% | -2.8% | -0.7% | +11.7% | +130.7% | -10.8% | +4.1% | +5.4% | |
| – | +18.9% | -3.5% | +9.5% | +42.1% | -4.8% | -1.2% | +17.5% | +99.2% | -20.7% | +9.0% | +10.6% | |
| – | +2.7% | +2.8% | +2.8% | +57.6% | +12.0% | +3.4% | +3.2% | +3.2% | -6.0% | +66.7% | -39.1% | |
| – | +69.5% | -23.2% | -58.2% | +411.1% | -5.1% | -3.5% | -9.7% | +18.3% | +8.8% | +24.4% | -43.2% | |
| – | +0.7% | +0.6% | +0.4% | +0.4% | +0.4% | +0.4% | +0.3% | +187.0% | +0.0% | +0.1% | +0.1% | |
| – | +1,721.8% | +109.9% | +0.7% | -9.3% | -2.9% | -5.8% | -2.1% | -10.1% | -3.7% | -9.8% | -3.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.0% | +1.2% | +7.0% | +1.6% | +0.8% | +0.7% | +0.5% | +1.2% | -0.2% | +29.4% | +0.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.